NLRP1 and CARD8 Inflammasomes: Assembly, Regulation and Stress Sensing
Project Number5R01AI124491-07
Former Number5R01AI124491-05
Contact PI/Project LeaderWU, HAO
Awardee OrganizationBOSTON CHILDREN'S HOSPITAL
Description
Abstract Text
Abstract
Nucleotide-binding domain (NBD)-like and leucine-rich repeat (LRR)-containing proteins (NLRs)
perform diverse functions in cellular biology, mediating a broad set of fundamental biological
pathways from immune signaling to embryonic development. In immunity, several NLRs form
supramolecular protein signaling complexes called inflammasomes. Inflammasomes activate
caspase-1, an inflammatory protease that processes the cytokine interleukin-1β (IL-1β) and the
pore-forming protein gasdermin D to potentiate pyroptotic cell death. One such inflammasome-
forming protein, NLRP1, is directly activated in response to intracellular pathogens and the
inhibition of DPP9, an endogenous peptidase, serving as both a pattern recognition receptor
and a signaling complex. While most NLRs share a common domain architecture, the
multifunctionality and regulation of NLRP1 requires additional structural components.
In addition to the characteristic NBD and LRR domains, human NLRP1 contains an N-
terminal pyrin domain (PYD) and a rare function-to-find domain (FIIND) followed by a caspase
activation and recruitment domain (CARD) on its C-terminus. The only other protein with a
FIIND is CARD8, which has also been shown to form inflammasomes, leading to cytokine
secretion and cell death. Mechanistically, the NLRP1 and CARD8 FIIND domains constitutively
catalyze autoproteolytic cleavage, leading to the formation of two noncovalently associated
peptides: an autoinhibitory N-terminal fragment and an inflammatory C-terminal fragment.
Additionally, Dipeptidyl peptidase 8 or 9 (DPP8/9) binds and inhibits NLRP1 and CARD8, and
small molecule inhibitors of DPP8/9 induces NLRP1 and CARD8 activation through some poorly
understood pathway. In this application, we propose to elucidate the activation and regulation of
NLRP1 and CARD8 using a structure-guided approach. We will determine structures of NLRP1
or CARD8 in complex with DPP8 or DPP9, both WT and mutants. We will analyze the structures
and perform additional biochemical and cellular biological experiments to test our hypotheses.
In one central aim, we propose that NLRP1 and CARD8 are stress sensors for endogenous
cellular dysregulation and play important roles in unwanted inflammation and diseases.
Public Health Relevance Statement
Inflammasome pathways are highly complex, rendering them susceptible to interruption
and dysregulation, leading to its association with many human diseases, such as
autoinflammatory diseases, and autoimmune diseases. For NLRP1, which expresses
highly in human keratinocytes, its germline mutations lead to many skin-related
inflammatory diseases with constitutive inflammasome activation and downstream
pyroptotic cell death. Both NLRP1 and CARD8 play additional roles in drug-induced
cancer cell death. Understanding both pathways at the molecular level would contribute
to human health and disease.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
076593722
UEI
Z1L9F1MM1RY3
Project Start Date
01-July-2016
Project End Date
30-June-2026
Budget Start Date
01-July-2022
Budget End Date
30-June-2023
Project Funding Information for 2022
Total Funding
$531,000
Direct Costs
$300,000
Indirect Costs
$231,000
Year
Funding IC
FY Total Cost by IC
2022
National Institute of Allergy and Infectious Diseases
$531,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI124491-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI124491-07
Patents
No Patents information available for 5R01AI124491-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI124491-07
Clinical Studies
No Clinical Studies information available for 5R01AI124491-07
News and More
Related News Releases
No news release information available for 5R01AI124491-07
History
No Historical information available for 5R01AI124491-07
Similar Projects
No Similar Projects information available for 5R01AI124491-07